Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Capital Expenditures: 2016-2025

Historic Capital Expenditures for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to $188,000.

  • Collegium Pharmaceutical's Capital Expenditures fell 22.95% to $188,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 30.10%. This contributed to the annual value of $1.7 million for FY2024, which is 258.35% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Capital Expenditures stood at $188,000 for Q3 2025, which was up 189.23% from $65,000 recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Capital Expenditures ranged from a high of $940,000 in Q4 2022 and a low of $56,000 during Q2 2023.
  • Over the past 3 years, Collegium Pharmaceutical's median Capital Expenditures value was $188,000 (recorded in 2025), while the average stood at $287,636.
  • Its Capital Expenditures has fluctuated over the past 5 years, first tumbled by 88.51% in 2021, then spiked by 382.14% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Capital Expenditures (Quarterly) stood at $515,000 in 2021, then surged by 82.52% to $940,000 in 2022, then crashed by 82.55% to $164,000 in 2023, then spiked by 247.56% to $570,000 in 2024, then decreased by 22.95% to $188,000 in 2025.
  • Its Capital Expenditures was $188,000 in Q3 2025, compared to $65,000 in Q2 2025 and $798,000 in Q1 2025.